Muhajiran, Abdul Nakir B.
HRN: 22-28-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/04/2022
12/11/2022
IV
115ng
Q8hours
Aspiration Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes